Boskonect

Boskonect is a branded generic pharmaceutical and nutraceutical product developed by Tabq Therapeutics, primarily indicated for the management of joint pain and inflammation associated with osteoarthritis. The active ingredient in Boskonect is typically **Boswellia serrata extract**, often standardized as **Aflapin**, a specialized and synergistic composition derived from the gum resin of the *Boswellia serrata* tree (Indian Frankincense). The therapeutic effect of Boskonect is mediated through the selective inhibition of the **Arachidonate 5-lipoxygenase (5-LOX)** enzyme, which is a key mediator in the biosynthesis of pro-inflammatory leukotrienes. By blocking the 5-LOX pathway, Boskonect reduces the inflammatory cascade within joint tissues, thereby alleviating symptoms such as pain and stiffness while improving physical mobility in patients with degenerative joint conditions.

Brand names

Boskonect

Other names

AflapinBoswellia serrata extract